Physician profile
Ross Mchenry
NPI 1720084353
$1,716.61
in general payments reported to CMS, 2019-2025
26 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $660 · 2020: $227 · 2021: $532 · 2022: $241 · 2023: $55.95.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $55.95.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $55.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $461.46 | 2019-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $267.34 | 2019-2022 | |
| Fujifilm Healthcare Americas Corporation | $170.09 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $131.70 | 2019-2021 | |
| Daiichi Sankyo INC. | $108.03 | 2019-2023 | Injectafer |
| Celgene Corporation | $76.75 | 2021-2022 | |
| Janssen Biotech, INC. | $67.00 | 2021 | |
| Pfizer INC. | $62.14 | 2019-2022 | |
| Intercept Pharmaceuticals, INC. | $39.23 | 2019 | |
| Nestle Healthcare Nutrition INC. | $36.57 | 2021-2022 | |
| Qol Medical, LLC | $33.55 | 2019-2021 | |
| Lilly USA, LLC | $29.56 | 2023 | |
| Ironwood Pharmaceuticals, INC | $27.62 | 2020 | |
| Evoke Pharma, INC. | $27.23 | 2021-2022 | |
| Medtronic, INC. | $25.74 | 2021 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $18.30 | 2022 | |
| Amgen INC. | $17.97 | 2020 | |
| Gilead Sciences, INC. | $15.31 | 2019 | |
| Shire North American Group INC | $14.62 | 2019 | |
| Ucb, INC. | $13.23 | 2020 | |
| Ferring Pharmaceuticals INC. | $12.85 | 2019 | |
| Alfasigma USA, INC. | $12.54 | 2020 | |
| Redhill Biopharma INC. | $12.29 | 2020 | |
| Endo Pharmaceuticals INC. | $12.15 | 2020 | |
| Braintree Laboratories, INC. | $11.68 | 2020 | |
| Dova Pharmaceuticals | $11.66 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ross Mchenry listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.